-
Prof. Lee Bernstein (University of California - Berkeley/LBNL)18/06/2026, 18:30Oral PresentationsInvited Abstract
225Ac and 212Pb are at the core of over 3 dozen current pre-clinical and clinical studies as of January 2024 that have the potential of addressing upwards of 1.3 million cancer patients in the US alone. Radiochemically-pure 225Ac can be extracted from 229Th (7880 y), which is itself a decay product of 233U (159,000 y) while...
Go to contribution page -
Prof. Lee Bernstein (University of California - Berkeley/LBNL)
Choose timezone
Your profile timezone: